Recombinant osteopontin in cerebral vasospasm after subarachnoid hemorrhage.
Suzuki
Hidenori
H
Department of Physiology, Loma Linda University of Medicine, Loma Linda, CA 92354, USA.
Hasegawa
Yu
Y
Chen
Wanqiu
W
Kanamaru
Kenji
K
Zhang
John H
JH
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002536:Cerebral Arteries / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D004347:Drug Interactions; D054638:Dual Specificity Phosphatase 1 / Q000378:metabolism; D007276:Injections, Intraventricular; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage; D053495:Osteopontin / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D034741:RNA, Small Interfering / Q000008:administration & dosage; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D013345:Subarachnoid Hemorrhage / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D015854:Up-Regulation; D020301:Vasospasm, Intracranial / Q000150:complications / Q000378:metabolism / Q000517:prevention & control*
D009842:Oligopeptides; D034741:RNA, Small Interfering; D011994:Recombinant Proteins; D053495:Osteopontin; C058161:glycyl-arginyl-glycyl-aspartyl-seryl-proline; D054638:Dual Specificity Phosphatase 1